BridgeBio Pharma, Inc. (BBIO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.19B |
| Enterprise value | 6.40B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 21.49 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 687.96 |
| Enterprise value/EBITDA | -11.32 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 102.78% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 44.32 |
| 52-week low 3 | 12.75 |
| 50-day moving average 3 | 28.77 |
| 200-day moving average 3 | 30.86 |
Share statistics
| Avg vol (3-month) 3 | 1.69M |
| Avg vol (10-day) 3 | 1.6M |
| Shares outstanding 5 | 187.13M |
| Implied shares outstanding 6 | 187.13M |
| Float 8 | 115.78M |
| % held by insiders 1 | 5.27% |
| % held by institutions 1 | 90.55% |
| Shares short (15 Apr 2024) 4 | 15.07M |
| Short ratio (15 Apr 2024) 4 | 9.67 |
| Short % of float (15 Apr 2024) 4 | 12.43% |
| Short % of shares outstanding (15 Apr 2024) 4 | 8.06% |
| Shares short (prior month 15 Mar 2024) 4 | 13.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -246.23% |
| Operating margin (ttm) | 1.77% |
Management effectiveness
| Return on assets (ttm) | -40.08% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 218.6M |
| Revenue per share (ttm) | 1.29 |
| Quarterly revenue growth (yoy) | 11,461.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -466.45M |
| Net income avi to common (ttm) | -538.26M |
| Diluted EPS (ttm) | -3.23 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 519.69M |
| Total cash per share (mrq) | 2.91 |
| Total debt (mrq) | 1.73B |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 6.37 |
| Book value per share (mrq) | -5.87 |
Cash flow statement
| Operating cash flow (ttm) | -602.93M |
| Levered free cash flow (ttm) | -402.05M |
© 2024 Yahoo. All rights reserved.